ZTS Stock Price, Chart, Stats & News

Zoetis Inc.
Save
ZTS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 70.49% |
Operating margin | 38.00% |
Pretax margin | 35.49% |
Net margin | 28.23% |
Effective tax rate | 20.45% |
ROA | 17.28% |
ROE | 58.23% |
D/E | 2.85x |
Interest coverage ratio | 15.11x |
ZTS valuation
P/E | 12.90x |
P/S | 5.28x |
P/B | 14.91x |
P/CF | 17.10x |
P/FCF | 21.87x |
P/OCF | 17.10x |
PEG | 12.26x |
EV multiple | 10.46x |
About
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents.
Similar securities
Based on sector and market capitalization
Report issue











